- Perimeter Medical Imaging AI has launched the OCT-Tissue Surveillance Registry to advance AI algorithm development for medical imaging.
- The registry aims to collect thousands of surgical images and data to enhance product development and reduce the need for second surgeries.
- Perimeter's B-Series OCT with ImgAssist AI 2.0 is under FDA review, integrating AI to aid breast-conserving surgeries.
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) has announced the launch of the OCT-Tissue Surveillance Registry, a database intended for collecting a significant volume of surgical images and data using the company's proprietary imaging technology. This initiative is geared towards enhancing Perimeter's AI deep-learning model and driving future product development.
The existing S-Series OCT technology offers real-time, ultra-high-resolution visualization of tissue samples during surgical procedures, aiding surgeons in real-time margin assessments. The next-generation B-Series OCT, equipped with ImgAssist AI 2.0, is currently under premarket approval review by the U.S. FDA. This advanced system integrates AI to assist in detecting suspicious tissues during breast-conserving surgeries.
Dr. Jennifer Tittensor, a general surgeon at Timpanogos Regional Hospital and an early adopter who has utilized Perimeter's OCT technology in over 120 surgeries, highlights its invaluable assistance in real-time margin assessments, potentially preventing the need for additional surgeries. The data collected in this registry will be instrumental for algorithm training, aiming to deliver more personalized patient care and improve surgical outcomes.
CEO Adrian Mendes commented on the initiative's potential to offer better clinical care by collaborating with physicians to gather high-quality images and data from a diverse patient population. This collective effort is expected to train Perimeter's AI algorithms to recognize tissue patterns more effectively, thereby contributing to more personalized surgical care and reducing second surgery rates due to residual cancer.
Healthcare providers interested in participating in the OCT-Tissue Registry can contact Perimeter Medical Imaging AI Clinical Affairs at [email protected] for further information.
